Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FMAU PET and MRI Radiomics in Brain Tumors
NCT04752267Phase 1Completed
- Sponsor
- University of Southern California
- Start
- Feb 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fluorine F 18 d-FMAU in brain neoplasm and brain metastasis (BM), sponsored by University of Southern California. Primary endpoints: Correlation between multiparametric magnetic resonance imaging (mpMRI) radiomics and dynamic fluorine F 18 (18F)-FAMU (FMAU) positron emission tomography (PET) kinetic analysis parameters at 1 year and Different pattern in radiomics mpMRI and FMAU PET kinetic analysis parameters at 1 year. Started Feb 2021; status: completed.
02
Drugs
fluorine F 18 d-FMAU
03
Conditions
brain neoplasmbrain metastasis (BM)
Beyond the preview
Go deeper on NCT04752267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04752267.